Meta-Analysis
Copyright ©The Author(s) 2022.
World J Cardiol. May 26, 2022; 14(5): 319-328
Published online May 26, 2022. doi: 10.4330/wjc.v14.i5.319
Figure 3
Figure 3 Secondary outcomes. A: Adverse event rates; B: Time to achieve fractional flow reserve (FFR) with adenosine versus regadenoson induced hyperemia for FFR measurement. CI: Confidence interval.